New Delhi The latest bulletin issued by Indian SARS-CoV-2 Genomics Consortium states that there was around 25% prevalence of recombinant variant XBB.1.16 in different parts of India till August. Besides, the public health risk of newly detected variant EG.5 was low worldwide with no disease severity reported so far. Based on the available evidence, the public health risk of EG.5 …